DD

DuPont de Nemours, Inc.
Basic MaterialsSpecialty ChemicalsNASDAQ
$48.42
+$1.30 (2.69%)today
Conviction
5/ 10
Fair Value$55.79
Upside+15.21%
Signal7.61
Market Cap$19.8B
52W Range$22.50–$52.66
Next EarningsMay 1

Conviction History

Conviction Changes

No conviction changes recorded

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Sign in to unlock

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid
Fair Value$22.55
Current Price$45.26
Upside / Down-50.2%
P(Undervalued)0.0%
P(20%+ Up)0.0%
P(15%+ Down)97.9%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

15.0%/yr

±7.5% · revenue growth to justify current price

FCF-Based Reverse DCF

63.0%/yr

±4.4% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Sign in to unlock
Bull Case

DuPont materials science transformation; semiconductor/water filtration growth segments.

Bear Case

Specialty chemicals demand tied to industrial capex cycle; divestiture execution risk.

Research Feed

sec_10kMar 3
Conviction: unchanged
DuPont FY2025 10-K: Transformation-Driven Contraction, Healthcare & Water Focus

Major transformation year completed: Qnity spin-off done, Aramids sale pending Q1 2026. Focus now pure-play healthcare/water + industrials. PFAS/litigation overhang remains material. Healthcare segmen...